Načítá se...
Building clinical trial capacity to develop a new treatment for multidrug-resistant tuberculosis
PROBLEM: New drugs for infectious diseases often need to be evaluated in low-resource settings. While people working in such settings often provide high-quality care and perform operational research activities, they generally have less experience in conducting clinical trials designed for drug appro...
Uloženo v:
| Vydáno v: | Bull World Health Organ |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
World Health Organization
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4750433/ https://ncbi.nlm.nih.gov/pubmed/26908964 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2471/BLT.15.154997 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|